Summary of my Dividend Growth Portfolio 2025


This portfolio only concentrate on small amount of DCA monthly. As Trump commenced global tariff causing market uncertainty, I remind myself to keep investing on the good fundamental businesses when temporary weakness. I viewed tariff won’t last long so I continued to invest only in DBS because the price seems to reasonable yet slightly expensive.

In second quarter, after reading  sheng siong's annual report  on expanding their outlets which align HDB Master plan and upcoming CDC vouchers, may boost their revenues that given me a sense of confident in Sheng Siong future growth and their defensive approach. I just need to remind myself Sheng Siong does contribute massive dividend but the future value and increase dividend are worth to invest in this portfolio. Decreasing DCA in DBS because the price is overprice  while NII start to slow down as the fed cutting rate.

The third and last quarter, I continued to DCA in Sheng Siong for its strong fundamental during these period I invested a new stock, SGX. I believe the share price is fair but there’s a growth story on IPO and new Index happening; in dividend wise there’s DPS increase and payout ratio decrease creating a meaningful dividend for this portfolio. I selloff some of the mapletree industrial trust because I realised reits does not create a meaningful dividend due to leverage, payout ratio policy.

In conclusion, I’m still tracking on DBS, Sheng siong and SGX to be my core. I’m just waiting whenever there’s a chance to buy DBS as the Money Printing started in Dec. Noticed diversify evenly is important in stock allocation overly concentrate on DBS may cause the portfolio up-and-down. In 2026, I will minimise dividend reinvestment and wait for better opportunities.

Comments

Popular posts from this blog

DBS Full year 2024 report and thoughts

Mid-year 2025 report

Sheng Siong FY 2024 thoughts and research